Watchlist

Watchlist
Amarin Corporation plc (AMRN)
Amarin Corporation plc (AMRN)
Amarin (AMRN) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
The following slide deck was published by Amarin Corporation PLC in conjunction with this Read more …
After Hours Gainers / Losers
Top gainers: CCIH +15.9% . CFMS +13.4% . SONC +5.2% . AMRN +3.8% . IONS +3.1% . More news on: ChinaCache International, ConforMIS, Sonic Corp., Stocks on the move, Read more …
Amarin sees $230M in sales this year; shares up 3% after hours
Amarin (NASDAQ: AMRN ) updates investors on Q4 and its outlook for 2018: More news on: Amarin Corporation PLC, Healthcare stocks news, Stocks on the move, Read more …
Your Daily Pharma Scoop: Synergy's New CEO, AbbVie Data, TiGenix Changes
Content Analysis of coverage: SGYP Stocks in the news: ABBV, TIG, EGLT Analyst Ratings Insider Sales Insider Purchases Secondary Offerings Earnings Report Earnings Calendar Analysis of top Seeking Alpha coverage: Synergy Pharmaceuticals Today …
Amarin nearing finish line with large-scale REDUCE-IT study, final study visits to start next quarter
Investors in Amarin (NASDAQ: AMRN ) are, no doubt, encouraged by the news that its multiyear large-scale cardiovascular outcomes study, REDUCE-IT , aimed at expanding the label of Vascepa is finally nearing its end . Final study visits will commence on March 1, 2018. Topline results should…
Your Daily Pharma Scoop: Conatus Looks Undervalued, Teva Announces Restructuring, Bristol-Myers Signs Licensing Agreement
Content Analysis of coverage: CNAT Stocks in the news: TEVA, BMY Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea of the Day (for TPT subscribers only) Subscriber Questions & Answers…
Your Daily Pharma Scoop: Geron Update, Acorda Resubmits NDA, Sage Rallies
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea…
Amarin Corporation: Strong Q3 Numbers, Solid Future Prospects, Extremely Boring Present
Summary and strategy : Amarin Corporation plc (NASDAQ: AMRN ) is a boring stock. Despite an approved drug that is doing very well in the market, with sales up 43% in just released Q3 data, the stock has remained rangebound for almost four years now. Take a look for yourself: Source: Go…
Your Daily Pharma Scoop: Acadia Valuation, Galectin Plunges, Revance Positive Result
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Total Pharma Tracker subscribers get the full version with actionable ideas one day ea…
Amarin: A Likely Runner In 2018
Shares of Amarin Corporation ( AMRN ) have risen by 20% since my initial article on the company back in May, in which I told readers to expect a run up shortly. While shares did increase by almost half at one point, the stock has come back down although it remains in an uptrend. AMRN data …
Amarin Corporation plc (AMRN)